Daridorexant

Indication

Treating long-term insomnia (NICE TA922)

NICE TA922 - Daridorexant for treating long-term insomnia

Green (Restricted)

Brand:

Quviviq

Nice TA:

922

Commissioning responsibility:

CCG

PbR excluded:

BNF chapter:

Central nervous system

Background

Please note: Following the publication of further information from NHS England, LSCMMG will produce guidance to support the use of daridorexant in Lancashire and South Cumbria.

Recommendation

LSCMMG Recommendation:

Green (Restricted)

Reason for decision:

Suitable for initiation in primary care in line with restrictions

Supporting documents:

Decisions of Lancashire local decision making groups

BwD	BP	CSR	EL	FW	GP	MB	WL
Green (R)(Restricted)	Green (R)(Restricted)	Green (R)(Restricted)	Green (R)(Restricted)	Green (R)(Restricted)	Green (R)(Restricted)	Green (R)(Restricted)	Green (R)(Restricted)

What do the colours mean?

Last Updated: 30 - Apr - 2024

Breadcrumb

Daridorexant

Indication

Background

Recommendation

Decisions of Lancashire local decision making groups